ORBIMED ADVISORS LLC – Mirati Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$99.09M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+4.04%
quarter
Mirati Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +30.13% | 328.49K shares | 25.89M | $69.84 | 1.41M |
| Q2 2022 | share | Decrease | -33.12% | -540.1K shares | -60.86M | $67.13 | 1.09M |
| Q1 2022 | share | Increase | +14.31% | 204.1K shares | -75.17M | $82.22 | 1.63M |
| Q4 2021 | share | Increase | +3.87% | 53.2K shares | -33.69M | $148.23 | 1.42M |
| Q3 2021 | share | Increase | +8.62% | 109K shares | 38.72M | $176.91 | 1.37M |
| Q2 2021 | share | Increase | +3.52% | 43K shares | -4.98M | $161.53 | 1.26M |
| Q1 2021 | share | Increase | +6.63% | 75.9K shares | -42.36M | $171.3 | 1.22M |
| Q4 2020 | share | Decrease | -13.04% | -171.7K shares | 32.86M | $219.64 | 1.14M |
| Q3 2020 | share | Decrease | -0.54% | -7.1K shares | 67.51M | $166.05 | 1.31M |
| Q2 2020 | share | Decrease | -6.97% | -99.2K shares | 41.76M | $114.17 | 1.32M |
| Q1 2020 | share | Increase | +6.17% | 82.7K shares | -63.34M | $76.87 | 1.42M |
| Q4 2019 | share | Increase | +150.51% | 805.45K shares | 131.05M | $128.86 | 1.34M |
| Q3 2019 | share | Increase | 0.00% | 535.14K shares | 41.69M | $77.91 | 535.14K |
| Q2 2016 | share | Decrease | -100.00% | -197.85K shares | -4.23M | $5.46 | 0 |
| Q1 2016 | share | Increase | +514.47% | 165.65K shares | 3.21M | $21.4 | 197.85K |